Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Dingdang Health Technology Group Ltd. ( (HK:9886) ) is now available.
Dingdang Health Technology Group Ltd. announced leadership changes effective February 16, 2026, with executive director and vice president Yu Lei resigning from all positions in the group for personal career reasons. The board noted that Yu has no disagreement with the company and expressed appreciation for his contributions during his tenure.
The company concurrently appointed long-serving manager Meng Fanzhou as executive director and vice president, formalizing his role in overseeing daily operations at core subsidiary Dingdang Medicine Express Technology. Meng, who has been with the group since 2015 and holds equity incentives via restricted shares and units, has signed a three-year renewable service contract, signaling continuity in operational management and internal succession planning for the group’s leadership structure.
More about Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. is a Hong Kong-listed company operating in the healthcare and pharmaceutical technology sector through its group entities. Its business includes online healthcare services and medicine distribution, with Dingdang Medicine Express Technology Group Ltd. acting as the holding company for its integrated affiliated entities and managing daily operations.
Average Trading Volume: 1,612,142
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.17B
Learn more about 9886 stock on TipRanks’ Stock Analysis page.